http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-385250-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01c1e0bc0628f76dea731cda5a666ca1 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-438 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-541 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5383 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-536 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438 |
filingDate | 1996-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2000-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4a730bae4bd2421a62931d811511084 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e5932efa6ffcf9cfaeacfd201ead1570 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8a7d3979e29bc356efe90e03ff06edd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8632dc759cc1e3e84111f3d55fc24c0d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94652dd0a586b00845ca0812e45cf07e |
publicationDate | 2000-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | TW-385250-B |
titleOfInvention | Treating agent for diseases due to infection with helicobacter |
abstract | A treating agent for a digestive apparatus disease due to infection with Helicobacter comprising as an essential ingredient a rifamycin derivative represented by formula (I) or formula (II), or a physiologically acceptable salt thereof; wherein X1 is oxygen atom or sulfur atom, R1 is acetyl group or hydrogen atom, R2 is hydroxyl group or hydrogen atom, and R3 is a group represented by formula (III); wherein R4 and R5 are the same or mutually different and each is an alkyl group having 1 to 3 carbon atoms or a group represented by formula (IV) wherein m is an integer selected from 1 to 3; or a group represented by formula (V) wherein R6 and R7 are the same or mutually different and each is hydrogen atom or an alkyl group having 1 to 3 carbon atoms, X2 is oxygen atom, sulfur atom or a group represented by formula: NR8 wherein R8 is hydrogen atom, an alkyl group having 1 to 6 atoms or a group represented by formula: -(CH2)nX3 wherein n is an integer selected from 1 to 4, and X3 is an alkoxyl group having 1 to 3 carbon atoms, vinyl group, ethynyl group or a group represented by formula (VI). And the formula (II) wherein R9 is an alkyl group having 1 to 7 carbon atoms. |
priorityDate | 1995-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 86.